Replies to post #665149 on NorthWest Biotherapeutics Inc (NWBO)

[abeta]

Thanks

When I have time going to hit all the tabs on their web site.

I'm concerned somebody using an approved drug and this vaccine runs
an end run around us

based on Direct we should know how their product did in the 3 indications
in about 6 months - at the latest.

maybe Doc knows who this is

anyway

[abeta]

Bill
https://www.orbishealthsolutions.com/immuno-oncology

I would say they are equal to or ahead of Direct.

Pipeline
https://www.eliostherapeutics.com/pipeline

Through our subsidiary, Elios Therapeutics, Orbis is developing the Tumor Lysate, Particle Only (TLPO) vaccine, an autologous (or personalized) therapeutic cancer vaccine designed to stimulate the immune system to recognize tumor cells and fight a patient’s specific cancer.

The vaccine is concurrently initiating a basket trial in patients with solid tumors and moving into a Phase 3 registrational trial for advanced stage melanoma patients based on a positive Phase IIb study showing the vaccine was safe and effective.

https://www.orbishealthsolutions.com/immuno-oncology